Hab ich über 3 Ecken gehört. Firma AXARON, das Medikament heißt AX 205. Axaron gehört zur BASF, internetmässig ist aber nur eine englische oder amerikanische Webseite zu finden. Darunter ist zu lesen:
AX205
AX205 is Axaron’s most advanced compound for the treatment of Amyotrophic Lateral Sclerosis (ALS). This product is in late stage pre-clinical testing and the company expects to start patient studies at the beginning of 2004.
Work in pre-clinical models to-date has shown that AX205 is capable of delaying the severe symptoms of ALS and the fatal outcome of the disease in animal models.
ALS is a progressive fatal neurological disease for which there is currently no cure. At present there are about 30,000 patients in the industrialized world who suffer from ALS. The only drug, which is approved for this indication is Rilutek®. Clinical trials have shown, however, that it is only able to modestly extend the life span of ALS patients. Axaron hopes that AX205 might be able to further improve the life expectancy as well as the quality of life of ALS patients.
AX205
AX205 is Axaron’s most advanced compound for the treatment of Amyotrophic Lateral Sclerosis (ALS). This product is in late stage pre-clinical testing and the company expects to start patient studies at the beginning of 2004.
Work in pre-clinical models to-date has shown that AX205 is capable of delaying the severe symptoms of ALS and the fatal outcome of the disease in animal models.
ALS is a progressive fatal neurological disease for which there is currently no cure. At present there are about 30,000 patients in the industrialized world who suffer from ALS. The only drug, which is approved for this indication is Rilutek®. Clinical trials have shown, however, that it is only able to modestly extend the life span of ALS patients. Axaron hopes that AX205 might be able to further improve the life expectancy as well as the quality of life of ALS patients.
Kommentar